GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Tax withholding / forfeiture | 1 | 1,360 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
58 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Adam Y. Holton - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 1,360 | $73.69 | $100K | |
| Kevin Lobo - Director | Open-market purchase | Common Stock, par value $0.01 per share | 10,000 | $64.18 | $642K | |
| Philip Rackliffe - Officer | Grant or award | Common Stock, par value $0.01 per share | 16,458 | $0.00 | - | |
| Jeannette Bankes - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 5,535 | $62.67 | $347K | |
| Rodney F. Hochman - Director | Open-market purchase | Common Stock, par value $0.01 per share | 1,618 | $62.03 | $100K | |
| Grant or award | Common Stock, par value $0.01 per share | 3,586 | $0.00 | - | ||
| Open-market purchase | Common Stock, par value $0.01 per share | 1,000 | $63.01 | $63K | ||
| Grant or award | Common Stock, par value $0.01 per share | 3,586 | $0.00 | - | ||
| Grant or award | Common Stock, par value $0.01 per share | 4,157 | $0.00 | - | ||
| Rodney F. Hochman - Director | Grant or award | Common Stock, par value $0.01 per share | 3,586 | $0.00 | - | |
| Rodney F. Hochman - Director | Grant or award | Common Stock, par value $0.01 per share | 2,689 | $0.00 | - | |
| Catherine A. Lesjak - Director | Grant or award | Common Stock, par value $0.01 per share | 3,586 | $0.00 | - | |
| Kevin Lobo - Director | Grant or award | Common Stock, par value $0.01 per share | 3,586 | $0.00 | - | |
| Grant or award | Common Stock, par value $0.01 per share | 3,586 | $0.00 | - | ||
| Grant or award | Common Stock, par value $0.01 per share | 2,282 | $0.00 | - | ||
| William J. Stromberg - Director | Grant or award | Common Stock, par value $0.01 per share | 3,586 | $0.00 | - | |
| Open-market purchase | Common Stock, par value $0.01 per share | 80,805 | $61.88 | $5.00M | ||
| William J. Stromberg - Director | Open-market purchase | Common Stock, par value $0.01 per share | 1,000 | $61.69 | $62K | |
| James Saccaro - Officer | Open-market purchase | Common Stock, par value $0.01 per share | 3,310 | $60.60 | $201K | |
| Kevin Lobo - Director | Grant or award | Common Stock, par value $0.01 per share | 777 | $0.00 | - | |
| Jeannette Bankes - Officer | Grant or award | Common Stock, par value $0.01 per share | 6,861 | $0.00 | - | |
| Jeannette Bankes - Officer | Grant or award | Employee Stock Option (right to buy) | 18,038 | $0.00 | - | |
| Grant or award | Common Stock, par value $0.01 per share | 10,915 | $0.00 | - | ||
| Grant or award | Employee Stock Option (right to buy) | 28,697 | $0.00 | - | ||
| Taha Kass-Hout - Officer | Grant or award | Common Stock, par value $0.01 per share | 13,254 | $0.00 | - | |
| Taha Kass-Hout - Officer | Grant or award | Employee Stock Option (right to buy) | 34,847 | $0.00 | - | |
| Adam Y. Holton - Officer | Grant or award | Common Stock, par value $0.01 per share | 5,457 | $0.00 | - | |
| Adam Y. Holton - Officer | Grant or award | Employee Stock Option (right to buy) | 14,348 | $0.00 | - | |
| Grant or award | Common Stock, par value $0.01 per share | 1,309 | $0.00 | - | ||
| Grant or award | Employee Stock Option (right to buy) | 3,443 | $0.00 | - | ||
| Grant or award | Common Stock, par value $0.01 per share | 6,549 | $0.00 | - | ||
| Grant or award | Employee Stock Option (right to buy) | 17,218 | $0.00 | - | ||
| Philip Rackliffe - Officer | Grant or award | Common Stock, par value $0.01 per share | 9,356 | $0.00 | - | |
| Philip Rackliffe - Officer | Grant or award | Employee Stock Option (right to buy) | 24,598 | $0.00 | - | |
| Roland Rott - Officer | Grant or award | Common Stock, par value $0.01 per share | 8,576 | $0.00 | - | |
| Roland Rott - Officer | Grant or award | Employee Stock Option (right to buy) | 22,548 | $0.00 | - | |
| James Saccaro - Officer | Grant or award | Common Stock, par value $0.01 per share | 12,475 | $0.00 | - | |
| James Saccaro - Officer | Grant or award | Employee Stock Option (right to buy) | 32,797 | $0.00 | - | |
| Peter J. Arduini - Officer | Grant or award | Common Stock, par value $0.01 per share | 49,120 | $0.00 | - | |
| Peter J. Arduini - Officer | Grant or award | Employee Stock Option (right to buy) | 129,140 | $0.00 | - | |
| Grant or award | Common Stock, par value $0.01 per share | 2,523 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 802 | $79.20 | $64K | ||
| Grant or award | Common Stock, par value $0.01 per share | 6,938 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 3,261 | $79.20 | $258K | ||
| Philip Rackliffe - Officer | Grant or award | Common Stock, par value $0.01 per share | 3,154 | $0.00 | - | |
| Philip Rackliffe - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 1,174 | $79.20 | $93K | |
| Roland Rott - Officer | Grant or award | Common Stock, par value $0.01 per share | 7,885 | $0.00 | - | |
| Roland Rott - Officer | Tax withholding / forfeiture | Common Stock, par value $0.01 per share | 3,943 | $79.20 | $312K |
GE HealthCare Technologies Inc. (GEHC) had 1 insider filing in the last 90 days, with the most recent on 2026-08-18. The full record for GEHC runs to 58 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of GEHC were filed in the last 90 days. 6 purchases are on record for this company.
No insider sales of GEHC were filed in the last 90 days. 2 sales are on record for this company.
This page tracks GEHC Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add GEHC to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.